Literature DB >> 12888113

The pathophysiology of falciparum malaria.

Ian A Clark1, William B Cowden.   

Abstract

Falciparum malaria is a complex disease with no simple explanation, affecting organs where the parasite is rare as well as those organs where it is more common. We continue to argue that it can best be understood in terms of excessive stimulation of normally useful pathways mediated by inflammatory cytokines, the prototype being tumor necrosis factor (TNF). These pathways involve downstream mediators, such as nitric oxide (NO) that the host normally uses to control parasites, but which, when uncontrolled, have bioenergetic failure of patient tissues as their predictable end point. Falciparum malaria is no different from many other infectious diseases that are clinically confused with it. The sequestration of parasitized red blood cells, prominent in some tissues but absent in others with equal functional loss, exacerbates, but does not change, these overriding principles. Recent opportunities to stain a wide range of tissues from African pediatric cases of falciparum malaria and sepsis for the inducible NO synthase (iNOS) and migration inhibitory factor (MIF) have strengthened these arguments considerably. The recent demonstration of bioenergetic failure in tissue removed from sepsis patients being able to predict a fatal outcome fulfils a prediction of these principles, and it is plausible that this will be demonstrable in severe falciparum malaria. Understanding the disease caused by falciparum malaria at a molecular level requires an appreciation of the universality of poly(ADP-ribose) polymerase-1 (PARP-1) and Na(+)/K(+)-ATPase and the protean effects of activation by inflammation of the former that include inactivation of the latter.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888113     DOI: 10.1016/s0163-7258(03)00060-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  55 in total

1.  Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-kappaB pathways for the expression of proinflammatory cytokines and nitric oxide.

Authors:  Jianzhong Zhu; Gowdahalli Krishnegowda; D Channe Gowda
Journal:  J Biol Chem       Date:  2004-12-15       Impact factor: 5.157

Review 2.  A surprising role for uric acid: the inflammatory malaria response.

Authors:  Julio Gallego-Delgado; Maureen Ty; Jamie M Orengo; Diana van de Hoef; Ana Rodriguez
Journal:  Curr Rheumatol Rep       Date:  2014-02       Impact factor: 4.592

3.  Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.

Authors:  Gordon A Awandare; Yamo Ouma; Collins Ouma; Tom Were; Richard Otieno; Christopher C Keller; Gregory C Davenport; James B Hittner; John Vulule; Robert Ferrell; John M Ong'echa; Douglas J Perkins
Journal:  Infect Immun       Date:  2006-10-23       Impact factor: 3.441

Review 4.  Pathogenesis of anemia in malaria: a concise review.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Parasitol Res       Date:  2007-09-16       Impact factor: 2.289

5.  Protection against Plasmodium chabaudi malaria induced by immunization with apical membrane antigen 1 and merozoite surface protein 1 in the absence of gamma interferon or interleukin-4.

Authors:  James M Burns; Patrick R Flaherty; Payal Nanavati; William P Weidanz
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 6.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Fatal Plasmodium falciparum, Clostridium perfringens, and Candida spp. Coinfections in a Traveler to Haiti.

Authors:  Gillian L Genrich; Julu Bhatnagar; Christopher D Paddock; Sherif R Zaki
Journal:  J Trop Med       Date:  2009-05-05

8.  Oral activated charcoal prevents experimental cerebral malaria in mice and in a randomized controlled clinical trial in man did not interfere with the pharmacokinetics of parenteral artesunate.

Authors:  J Brian de Souza; Uduak Okomo; Neal D Alexander; Naveed Aziz; Benjamin M J Owens; Harparkash Kaur; Momodou Jasseh; Sant Muangnoicharoen; Percy F Sumariwalla; David C Warhurst; Stephen A Ward; David J Conway; Luis Ulloa; Kevin J Tracey; Brian M J Foxwell; Paul M Kaye; Michael Walther
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

9.  Persistently elevated laboratory markers of thrombosis and fibrinolysis after clinical recovery in malaria points to residual and smouldering cellular damage.

Authors:  Anirban Dasgupta; Sandeep Rai; Amar Das Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2011-09-10       Impact factor: 0.900

10.  Polymorphisms in the Fc gamma receptor IIIA and Toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon levels.

Authors:  Elly O Munde; Winnie A Okeyo; Samwel B Anyona; Evans Raballah; Stephen Konah; Wilson Okumu; Lilian Ogonda; John Vulule; Collins Ouma
Journal:  Infect Immun       Date:  2012-10-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.